SecBot SecBot
8-K ·Filed Aug 13, 2026

RMTI

ROCKWELL MEDICAL, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001628280-26-056470
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

Monitor for any subsequent filings or press releases that may contain the actual content of the updated corporate presentation. Without the presentation, there is no actionable information from this filing.

DirectionNeutral
Confidencelow
Horizonimmediate
Latest settled — T+20d
RMTI ▲ +1.73% at T+20d
NEUTRAL call +1.73% · α vs SPY +3.47% · entry $7.83 → $7.96
Next anchor: T+60d in 10d
Latest observation: T+50 +3.24% FF3 residual α
Entry = T+0 close
Aug 13, 2026
via day close
T+1d
-5.30%
call -5.30% · α -5.11%
$7.41
settled 2mo ago
T+5d
-1.15%
call -1.15% · α +0.81%
$7.74
settled 2mo ago
T+20d
+1.73%
call +1.73% · α +3.47%
$7.96
settled 7w ago
T+60d
Pending
in 10d

Price Chart

Loading chart...

Executive Summary

Rockwell Medical, Inc. filed an 8-K on August 13, 2026, disclosing an updated corporate presentation under Item 7.01 Regulation FD. The presentation itself was not provided in the filing documents, so no specific financial data, guidance, or strategic updates are available for analysis. This is a routine disclosure of an investor presentation with no material new information.

Key Facts

  • Rockwell Medical filed an 8-K on August 13, 2026, making an updated corporate presentation available.
  • The filing is under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits).
  • The actual content of the corporate presentation (Exhibit 99.1) was not included in the provided documents, preventing analysis of any new information.

Financial Impact

No financial data available in the filing documents.

Risk Factors

  • Lack of visibility into the content of the updated corporate presentation.
  • Potential for material information to be disclosed in the presentation that is not yet reflected in the stock price.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-056470
Document: 0001628280-26-056470-index-headers.html0001628280-26-056470
Document: 0001628280-26-056470-index.html0001628280-26-056470
Document: 0001628280-26-056470.txt0001628280-26-056470
5 reports for RMTI
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for RMTI — sortable, filterable
TypeNow
Aug 13, 2026
10w ago
8-K
NEUTRAL ★ 2/10
$7.83awaiting T+60—$6.86 (−12.33%)
Jul 20, 2026
14w ago
8-K
NEUTRAL ★ 2/10
$6.30 $7.85▲ +24.70%▲ +19.86%$6.86 (+8.98%)
Jun 29, 2026
17w ago
8-K
NEUTRAL ★ 2/10
$0.5874 $0.8570▲ +45.90%▲ +42.28%$6.86 (+1067.86%)
May 8, 2026
24w ago
8-K
BEARISH ★ 7/10
$8.40 $7.26▲ +13.57%▲ +17.96%$6.86 (+18.33%)
May 7, 2026
24w ago
8-K
NEUTRAL ★ 2/10
$7.80 $7.23▼ −7.31%▼ −11.14%$6.86 (−12.05%)
Showing 5 of 5

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 13, 2026